Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Down's syndrome (DS) or trisomy 21 is the most common genetic cause of mental retardation. Development of the DS brain is associated with decreased neuronal number and abnormal neuronal differentiation, and adults with DS develop Alzheimer's disease. The cause of the neurodegenerative process in DS is unknown. Here we report that cortical neurons from fetal DS and age-matched normal brain differentiate normally in culture, but DS neurons subsequently degenerate and undergo apoptosis whereas normal neurons remain viable. Degeneration of DS neurons is prevented by treatment with free-radical scavengers or catalase. Furthermore, DS neurons exhibit a three- to fourfold increase in intracellular reactive oxygen species and elevated levels of lipid peroxidation that precede neuronal death. These results suggest that DS neurons have a defect in the metabolism of reactive oxygen species that causes neuronal apoptosis. This defect may contribute to mental retardation early in life and predispose to Alzheimer's disease in adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other biomarkers of increased oxidative damage in the brains of persons with DS and persons with DS with AD neuropathology (DS with AD) include elevated levels of HNE and PC15,42; the increases are greater in people with DS with AD62,65,66.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [62]
In the citing paper
“These oxidatively modified, and likely dysfunctional, proteins include ones associated with altered glucose metabolism, mTOR signaling (including inhibited autophagy and increased insulin resistance), and the proteostasis network42,61,62,65,66.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [62]
In the citing paper
“Analysis of such cortical neurons from fetuses, confirmed significantly increased levels of ROS responsible for apoptosis (Busciglio and Yanker 1995).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Busciglio and Yanker 1995
Citations
Cites
Cell Death: The Significance of Apoptosis
Wyllie, A. H., Kerr, J. F. R., & Currie, A. R. (1980) · International Review of Cytology · doi:10.1016/s0074-7696(08)62312-8 · Cited by 7,162
Bass, D. A., Parce, J. W., Dechatelet, L. R., Szejda, P., Seeds, M. C., & Thomas, M. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.4.1910 · Cited by 1,809
Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species
Kane, D., Sarafian, T., Anton, R., Hahn, H., Gralla, E., Valentine, J., Ord, T., & Bredesen, D. (1993) · Science · doi:10.1126/science.8235659 · Cited by 1,671
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Royall, J. A., & Ischiropoulos, H. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1222 · Cited by 1,119
Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037
Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay
Cathcart, R., Schwiers, E., & Ames, B. N. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90270-1 · Cited by 852
Greenlund, L. J. S., Deckwerth, T. L., & Johnson, E. M. (1995) · Neuron · doi:10.1016/0896-6273(95)90287-2 · Cited by 742
Programmed cell death and Bcl-2 protection in very low oxygen
Jacobson, M. D., & Raff, M. C. (1995) · Nature · doi:10.1038/374814a0 · Cited by 625
Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL
Shimizu, S., Eguchi, Y., Kosaka, H., Kamiike, W., Matsuda, H., & Tsujimoto, Y. (1995) · Nature · doi:10.1038/374811a0 · Cited by 611
Research works printed but not linked: 1
- Becker, L., Mito, T., Takashima, S. & Onodera, K. Prog. clin. biol. Res. 373, 133–152 (1991).
Cited by
Items 201–300 of 749
Apoptosis in neural development and disease: Figure 1
Mazarakis, N. D., Edwards, A. D., & Mehmet, H. (1997) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.77.3.f165 · Cited by 100
“Mental retardation in Down’s syndrome has also been linked to inappropriate apoptosis. Although cortical neurons from fetal Down’s syndrome brains differentiate normally in culture, they subsequently degenerate and undergo apoptosis.”
BackgroundBaud, O., Haynes, R. F., Wang, H., Folkerth, R. D., Li, J., Volpe, J. J., & Rosenberg, P. A. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03451.x · Cited by 91
Macrophages Offer A Paradigm Switch for CNS Delivery of Therapeutic Proteins
Klyachko, N. L., Haney, M. J., Zhao, Y., Manickam, D. S., Mahajan, V., Suresh, P., Hingtgen, S. D., Mosley, R. L., Gendelman, H. E., Kabanov, A. V., et al. (2014) · Nanomedicine · doi:10.2217/nnm.13.115 · Cited by 92
Cognition in Down syndrome: a developmental cognitive neuroscience perspective
Edgin, J. O. (2013) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1221 · Cited by 99
Nenoi, M., Ichimura, S., Mita, K., Yukawa, O., & Cartwright, I. L. (2001) · PubMed · Cited by 92
Mitochondrial dysfunction and Down's syndrome
Arbuzova, S., Hutchin, T., & Cuckle, H. (2002) · BioEssays · doi:10.1002/bies.10138 · Cited by 90
Gulesserian, T., Seidl, R., Hardmeier, R., Cairns, N., & Lubec, G. (2001) · Journal of Investigative Medicine · doi:10.2310/6650.2001.34089 · Cited by 90
Lu, J., Esposito, G., Scuderi, C., Steardo, L., Delli-Bovi, L. C., Hecht, J. L., Dickinson, B. C., Chang, C. J., Mori, T., & Sheen, V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022126 · Cited by 91
“Several studies using cultured DS neurons from fetal DS brain also support an early increase in oxidative stress leading to premature loss in neuronal viability [13,35].”
BackgroundBusciglio, J., Hartmann, H., Lorenzo, A., Wong, C., Baumann, K., Sommer, B., Staufenbiel, M., & Yankner, B. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-13-05101.1997 · Cited by 69
“Primary human cortical cultures were established from 15- to 17-week-gestation fetal abortuses as described previously (Busciglio and Yankner, 1995).”
MethodSelf-citationLee, M., Hyun, D., Jenner, P., & Halliwell, B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00107.x · Cited by 90
Oxidative stress and neural dysfunction in Down Syndrome
Iannello, R. C., Crack, P. J., de Haan, J. B., & Kola, I. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_17 · Cited by 93
“mally in culture but subsequently degenerate and undergo apoptosis whereas control neurons remain viable (Busciglio and Yankner, 1995).”
BackgroundIndomethacin-induced mitochondrial dysfunction and oxidative stress in villus enterocytes
Basivireddy, J., Vasudevan, A., Jacob, M., & Balasubramanian, K. A. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01067-5 · Cited by 89
Oxidative Damage in Neurodegenerative Diseases
Beal, M. F. (1997) · The Neuroscientist · doi:10.1177/107385849700300112 · Cited by 89
ets-2 Promotes the Activation of a Mitochondrial Death Pathway in Down's Syndrome Neurons
Helguera, P., Pelsman, A., Pigino, G., Wolvetang, E., Head, E., & Busciglio, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5107-04.2005 · Cited by 88
“DS HCNs exhibit intracellular oxidative stress and increased apoptosis after the first week in culture (Busciglio and Yankner, 1995).”
MethodInfluentialSelf-citationAnderson, A. J., Stoltzner, S., Lai, F., Su, J. H., & Nixon, R. A. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00126-3 · Cited by 93
Lott, I. T. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.010 · Cited by 82
Endogenous liver carcinogenesis in the rat *
Nakae, D. (1999) · Pathology International · doi:10.1046/j.1440-1827.1999.00990.x · Cited by 92
Hensley, K., Carney, J. M., Stewart, C. A., Tabatabaie, T., Pye, Q. N., & Floyd, R. A. (1996) · International review of neurobiology · doi:10.1016/s0074-7742(08)60725-4 · Cited by 93
Genetic factors in Alzheimer's disease: A review of recent advances
Levy‐Lahad, E., & Bird, T. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400604 · Cited by 96
A Cytopathogenic, Apoptosis-Inducing Variant of Hepatitis A Virus
Brack, K., Frings, W., Dotzauer, A., & Vallbracht, A. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.3370-3376.1998 · Cited by 85
Increased reactive oxygen species in familial amyotrophic lateral sclerosis with mutations in SOD1
Ahmed, M., Hung, W.-Y., Zu, J. S., Hockberger, P. E., & Siddique, T. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00317-8 · Cited by 85
Liu, T., Perry, G., Chan, H. W., Verdile, G., Martins, R. N., Smith, M. A., & Atwood, C. S. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02196.x · Cited by 86
Role of Founder Cell Deficit and Delayed Neuronogenesis in Microencephaly of the Trisomy 16 Mouse
Haydar, T. F., Nowakowski, R. S., Yarowsky, P. J., & Krueger, B. K. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04156.2000 · Cited by 83
“Studies of primary neuronal cultures from both DS and mouse Ts16 fetal brains have demonstrated large increases in cell death (Bambrick et al., 1995; Busciglio and Yankner, 1995).”
BackgroundCheon, M. S., Kim, S. H., Yaspo, M., Blasi, F., Aoki, Y., Melén, K., & Lübec, G. (2003) · Amino Acids · doi:10.1007/s00726-002-0336-2 · Cited by 84
“Therefore, comparable expression of CBR1 does not explain increased reactive oxygen species formation in primary cultures of DS fetal neurons ( Busciglio and Yankner, 1995 ) and elevated parameters that are known to be involved in the cellular oxidation in DS fetal brain (Odetti et al., 1998).”
BackgroundProtein expression in Down syndrome brain
Engidawork, E., & Lübec, G. (2001) · Amino Acids · doi:10.1007/s007260170001 · Cited by 87
“Using primary neurons obtained from fetal DS brain and age matched controls, Busciglio and Yankner (1995) showed that while cortical neurons obtained from both groups differentiate normally in culture, DS neurons subsequently degenerate and undergo apoptosis.”
BackgroundMethodProspects for Improving Brain Function in Individuals with Down Syndrome
Costa, A. C. S., & Scott-McKean, J. J. (2013) · CNS Drugs · doi:10.1007/s40263-013-0089-3 · Cited by 89
“Further support for this notion came from the landmark work by Busciglio and Yankner [72] showing that cortical neurons from aborted fetuses with DS”
ResultGranic, A., Padmanabhan, J., Norden, M., & Potter, H. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-10-0850 · Cited by 81
“Indeed, trisomy 21 neurons are prone to apoptosis, PS-1 mutation or overexpression (and thus increased A production) induces cell cycle defects in cultured cells, and mice harboring an FAD mutant human APP or PS-1 gene have reduced neurogenesis and other cell cycle defects (Wolozin et al., 1996; Busciglio and Yankner,…”
Multiple evidence for an early age pro-oxidant state in Down Syndrome patients
Pallardó, F. V., Degan, P., d’Ischia, M., Kelly, F. J., Zatterale, A., Calzone, R., Castello, G., Fernández‐Delgado, R., Dunster, C., Lloret, A., et al. (2006) · Biogerontology · doi:10.1007/s10522-006-9002-5 · Cited by 81
“This has been investigated in a number of in vitro, ex vivo, and animal studies (Brooksbank and Balasz 1984; Epstein et al. 1987; Kedziora and Bartosz 1988; Groner et al. 1994; Busciglio and Yankner 1995; Balcz et al. 2001; de Haan et al. 2003).”
BackgroundPrevention of motoneuron death by adenovirus-mediated neurotrophic factors
Gim�nez y Ribotta, M., Revah, F., Pradier, L., Loquet, I., Mallet, J., & Privat, A. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970501)48:3<281::aid-jnr11>3.0.co;2-4 · Cited by 104
Reactive Oxygen Species and Their Contribution to Pathology in Down Syndrome
de Haan, J. B., Wolvetang, E. J., Cristiano, F., Iannello, R. C., Bladier, C., Kelner, M. J., & Kola, I. (1996) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60992-8 · Cited by 84
Oxidative stress in Alzheimer's disease: Primary villain or physiological by-product?
Sutherland, G. T., Chami, B., Youssef, P., & Witting, P. K. (2013) · Redox Report · doi:10.1179/1351000213y.0000000052 · Cited by 75
Mazlan, M., Then, S., Top, G. M., & Ngah, W. Z. W. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.10.006 · Cited by 91
Structure of human erythrocyte catalase
Ko, T.-P., Safo, M. K., Musayev, F. N., Di Salvo, M. L., Wang, C., Wu, S.-H., & Abraham, D. J. (2000) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444999015930 · Cited by 73
“Catalase was shown to be effective in inhibiting the degeneration of neurons (Busciglio & Yankner, 1995).”
BackgroundBhattacharyya, A., McMillan, E., Chen, S. I., Wallace, K., & Svendsen, C. N. (2009) · Developmental Neuroscience · doi:10.1159/000236899 · Cited by 79
Dubreuil, M. M., Morgens, D. W., Okumoto, K., Honsho, M., Contrepois, K., Lee-McMullen, B., Traber, G. M., Sood, R. S., Dixon, S. J., Snyder, M. P., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.013 · Cited by 79
“Oxidative stress has diverse deleterious effects and can lead to tumorigenesis, cell death, neurological disease, and aging (Busciglio and Yankner, 1995; Conger and Fairchild, 1952; Cunningham et al., 1987; Finkel and Holbrook, 2000; Guo et al., 2011; Ishii et al., 2005; Liochev, 2013; Nagai et al., 2009; Sakurai et a…”
BackgroundLack of glutathione peroxidase-1 exacerbates Aβ-mediated neurotoxicity in cortical neurons
Crack, P. J., Cimdins, K., Ali, U., Hertzog, P. J., & Iannello, R. C. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0352-y · Cited by 83
“Necrosis, by comparison, is an unregulated, passive form of cell death characterized by swollen mitochondria and nuclei and by the loss of plasma membrane integrity (Busciglio and Yankner, 1995).”
BackgroundMurray, A., Letourneau, A., Canzonetta, C., Stathaki, E., Gimelli, S., Sloan-Bena, F., Abrehart, R., Goh, P., Lim, S., Baldo, C., et al. (2015) · Stem Cells · doi:10.1002/stem.1968 · Cited by 78
Down syndrome genetics: unravelling a multifactorial disorder
Hernandez, D., & Fisher, E. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.supplement_1.1411 · Cited by 96
Mazzola, J. L., & Sirover, M. A. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10484 · Cited by 76
Is it possible to improve neurodevelopmental abnormalities in Down syndrome?
Bartesaghi, R., Guidi, S., & Ciani, E. (2011) · revneuro · doi:10.1515/rns.2011.037 · Cited by 75
“Apoptotic cell death (humans) Cultured neurons from the fetal DS brain exhibit an increased occurrence of apoptosis (Busciglio and Yankner, 1995 ; Busciglio et al., 2002 ; Pelsman et al., 2003 ; Helguera et al., 2005 ).”
BackgroundLucius, R., & Sievers, J. (1996) · Brain Research · doi:10.1016/s0006-8993(96)01029-3 · Cited by 88
Di Domenico, F., Pupo, G., Mancuso, C., Barone, E., Paolini, F., Arena, A., Blarzino, C., Schmitt, F. A., Head, E., Butterfield, D. A., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-141254 · Cited by 75
“Similar to AD [71] [72] [73] [74], A accumulation in DS is associated with enhanced formation of reactive oxygen species in neurons leading to premature neuronal dysfunction and death [75] [76] [77].”
Tiberi, J., Cesarini, V., Stefanelli, R., Canterini, S., Fiorenza, M. T., & Rosa, P. L. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111802 · Cited by 81
Neurodevelopmental and psychiatric issues in Down’s syndrome: assessment and intervention
Vicari, S., Pontillo, M., & Armando, M. (2013) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32835fe426 · Cited by 68
“antioxidants (Brooksbank and Balazs, 1984; Busciglio and Yankner, 1995).”
BackgroundApolipoprotein A‐I: Insights from redox proteomics for its role in neurodegeneration
Keeney, J. T. R., Swomley, A. M., Förster, S., Harris, J. L., Sultana, R., & Butterfield, D. A. (2013) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201200087 · Cited by 72
“Increased oxidative stress, indexed by ROS and lipid peroxidation, has been shown in DS neurons [116].”
BackgroundAneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer's disease
Zekanowski, C., & Wojda, U. (2009) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2009-1748 · Cited by 73
“In turn, apoptotic stimulus could be more effective in aneuploidic cells, as shown in cortical neurons from DS fetuses, and in aneuploidic neurons from AD patients (Busciglio and Yankner 1997, Herrup et al. 2004).”
BackgroundOvchinnikov, D. A., Korn, O., Virshup, I., Wells, C. A., & Wolvetang, E. J. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.05.004 · Cited by 70
Corrales, A., Martínez, P., García, S., Vidal, V., García, E., Flórez, J., Sanchez‐Barceló, E. J., Martínez‐Cué, C., & Rueda, N. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12037 · Cited by 69
“Both DS individuals and TS mice present with enhanced oxidative stress leading to premature neuronal dysfunction and cell death [2, 18, 58, 59].”
BackgroundPrenatal Neurobiological Development: Molecular Mechanisms and Anatomical Change
Monk, C. S., Webb, S. J., & Nelson, C. A. (2001) · Developmental Neuropsychology · doi:10.1207/s15326942dn1902_5 · Cited by 64
“For example, neurons from fetuses with Down’s syndrome experienced high rates of apoptosis when they were cultured relative to controls (Busciglio & Yankner, 1995).”
BackgroundApoptosis and extracellular matrix–cell interactions in kidney disease
Makino, H., Sugiyama, H., & Kashihara, N. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07711.x · Cited by 74
“However, apoptosis may also play a pathologic role that is not beneficial for the tissue in relationship to certain neurodegenerative disorder”
BackgroundReduction of Lower Motor Neuron Degeneration inwobblerMice byN-Acetyl-l-Cysteine
Henderson, J. T., Javaheri, M., Kopko, S., & Roder, J. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-23-07574.1996 · Cited by 73
The role of oxidative stress in postoperative delirium
Karlidag, R., Unal, S., Sezer, O. H., Bay Karabulut, A., Battaloğlu, B., But, A., & Ozcan, C. (2006) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2006.06.002 · Cited by 72
“This increased production of H2O2 during CPB surgery is likely to induce delirium [47,52].”
BackgroundAmstad, P., Liu, H., Ichimiya, M., Berezesky, I. K., Trump, B. F., Buhimschi, I. A., & Gutiérrez, P. L. (2001) · Redox Report · doi:10.1179/135100001101536535 · Cited by 75
Seidl, R., Fang-Kircher, S. G., Bidmon, B., Cairns, N. J., & Lübec, G. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00945-8 · Cited by 78
ApoE, Alzheimer's Disease, and Recovery from Brain Stressa
ROSES, A. D., & SAUNDERS, A. M. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48471.x · Cited by 73
Casillas, A. M., Hiura, T. S., Li, N., & Nel, A. E. (1999) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)62884-0 · Cited by 71
Kola, I. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.10.1713 · Cited by 71
“Intriguingly, cortical neurons from aborted Down syndrome conceptuses undergo neurodegeneration due to apoptosis at accelerated rates compared with non-Down syndrome aborted conceptuses and these effects appear to be mediated via increased levels of H 202; compounds such as N-acetylcysteine, vitamin E and catalase (49…”
BackgroundHu, R., & Kong, A. T. (2003) · Nutrition · doi:10.1016/j.nut.2003.09.015 · Cited by 73
The Role of Oxidative Stress in the Pathomechanism of Congenital Malformations
Laforgia, N., Mauro, A. D., Guarnieri, G. F., Varvara, D., Cosmo, L. D., Panza, R., Capozza, M., Baldassarre, M. E., & Resta, N. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7404082 · Cited by 76
“These evidences suggest that increased generation of ROS in fetal DS neurons leading to neuronal apoptosis may contribute to abnormal brain development and mental retardation and predispose to the early onset of Alzheimer’s disease in DS as well [28].”
BackgroundProtective Activity of Aromatic Amines and Imines against Oxidative Nerve Cell Death
Moosmann, B., Skutella, T., Beyer, K., & Behl, C. (2001) · Biological Chemistry · doi:10.1515/bc.2001.195 · Cited by 77
“Down’s syndrome neurons have been described to exhibit elevated intracellular levels of peroxides and an increased degree of lipid peroxidation (Busciglio and Yankner, 1995).”
BackgroundSchuchmann, S., & Heinemann, U. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00226-9 · Cited by 71
Praticò, D., Iuliano, L., Amerio, G., Tang, L. X., Rokach, J., Sabatino, G., & Violi, F. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200011)48:5<795::aid-ana15>3.0.co;2-# · Cited by 69
Khamphio, M., Barusrux, S., & Weerapreeyakul, N. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.06.017 · Cited by 69
Llorens-Martín, M., Rueda, N., Tejeda, G. S., Flórez, J., Trejo, J. L., & Martínez‐Cué, C. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.09.043 · Cited by 75
Asker, M. S., & Shawky, B. T. (2010) · Food Chemistry · doi:10.1016/j.foodchem.2010.04.037 · Cited by 68
Neuronal Proliferation, Migration, Organization, and Myelination
Volpe, J. J. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3995-2.10002-0 · Cited by 74
Beacher, F., Simmons, A., Daly, E., Prasher, V., Adams, C., Margallo-Lana, M. L., Morris, R., Lovestone, S., Murphy, K., & Murphy, D. G. M. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.12.1360 · Cited by 64
“Abnormalities in calcium signaling are also associated with apoptosis, which may be increased in trisomy 21 neurons.(27) Thus, variations in brain myo-inositol concentration may directly affect neuronal development, survival, and function.”
BackgroundGVS‐111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons
Pelsman, A., Hoyo‐Vadillo, C., Gudasheva, T. A., Seredenin, S. B., Ostrovskaya, R. U., & Busciglio, J. (2003) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(03)00031-5 · Cited by 65
“Degenerating DS neurons show increased intracellular levels of ROS, membrane blebbing, chromatin condensation and positive TUNEL staining consistent with apoptotic cell death (Busciglio and Yankner, 1995).”
BackgroundMethodResultInfluentialSelf-citationAlzheimer's Disease: Role of Aging in Pathogenesis
HARMAN, D. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02109.x · Cited by 64
Schuchmann, S., Müller, W., & Heinemann, U. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-18-07216.1998 · Cited by 66
Glutathione metabolism and antioxidant enzymes in children with down syndrome
Pastore, A., Tozzi, G., Gaeta, L. M., Giannotti, A., Bertini, E., Federici, G., Digilio, M. C., & Piemonte, F. (2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.203 · Cited by 63
Vitamin E in aging persons with Down syndrome: A randomized, placebo-controlled clinical trial
Sano, M., Aisen, P. S., Andrews, H. F., Tsai, W.-Y., Lai, F., Dalton, A. J., For the International Down Syndrome and Alzheimer's Disease Consortium, International Down Syndrome and Alzheimer's Disease Consortium, McCallion, P., Zendell, A., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002714 · Cited by 61
Fetal Malformations and Folate Metabolism: Review of Recent Evidence
Moyers, S. B., & Bailey, L. B. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2001.tb07013.x · Cited by 63
Gimeno, A., García‐Giménez, J. L., Audí, L., Torán, N., Andaluz, P., Dasí, F., Viña, J., & Pallardó, F. V. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.014 · Cited by 65
“It was reported that cells from DS, or animal model of DS are prone to oxidative stress and apoptosis and have lower proliferation capability [15–19].”
BackgroundHigh incidence of acute lung injury in children with Down syndrome
Bruijn, M., van der Aa, L. B., van Rijn, R. R., Bos, A. P., & van Woensel, J. B. M. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0803-z · Cited by 62
“One could speculate whether this is related to an imbalance in the antioxidant/oxidant status in patients with DS due to increased levels of superoxide dismutase 1, an important enzyme in the antioxidant pathway that is encoded for on chromosome 21 [22, 23].”
BackgroundInvolvement of cystatin C in oxidative stress-induced apoptosis of cultured rat CNS neurons
Nishio, C., Yoshida, K., Nishiyama, K., Hatanaka, H., & Yamada, M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02540-3 · Cited by 66
Nrf2 stabilization prevents critical oxidative damage in Down syndrome cells
Zamponi, E., Zamponi, N., Coskun, P., Quassollo, G., Lorenzo, A., Cannas, S. A., Pigino, G., Chialvo, D. R., Gardiner, K., Busciglio, J., et al. (2018) · Aging Cell · doi:10.1111/acel.12812 · Cited by 60
Self-citationGulesserian, T., Engidawork, E., Fountoulakis, M., & Lübec, G. (2001) · Springer eBooks · doi:10.1007/978-3-7091-6262-0_6 · Cited by 62
Free radicals and reactive oxygen species in programmed cell death
Anderson, K. M., Seed, T. M., Ou, D., & Harris, J. E. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0521 · Cited by 66
Lipids and the pathogenesis of Alzheimer's disease: Is there a link?
Mielke, M. M., & Lyketsos, C. G. (2006) · International Review of Psychiatry · doi:10.1080/09540260600583007 · Cited by 60
“…is underscored given that it is fundamentally different from other forms of free radical injury, such as protein or DNA peroxidation, in that it is a selfsustaining process, initially causing membrane damage then proceeding to apoptosis (Busciglio & Yankner, 1995; Porter, Caldwell, & Mills, 1995).”
BackgroundDirect measurement of oxygen free radicals during in utero hypoxia in the fetal guinea pig brain
Maulik, D., Numagami, Y., Ohnishi, S. T., Mishra, O. P., & Delivoria-Papadopoulos, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00408-9 · Cited by 62
Glutamatergic signaling in cellular transformation
Teh, J. L. F., & Chen, S. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.00983.x · Cited by 61
“Therefore, an increase in intracellular glutamate concentrations will result in a decrease in cystine transport and therefore reduce intracellular levels of GSH, exposing cells to oxidative stress and genomic instability (Busciglio and Yankner, 1995; Kato et al., 1992; Pereira and Oliveira, 1997).”
BackgroundPerluigi, M., Di Domenico, F., & Buttterfield, D. A. (2014) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201300066 · Cited by 59
“In line with these studies, neurons of DS patients are exposed to high intracellular ROS, which in turn induce lipid peroxidation [23].”
ResultMizuno, G. O., Wang, Y., Shi, G., Wang, Y., Sun, J., Papadopoulos, S., Broussard, G. J., Unger, E. K., Deng, W., Weick, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.033 · Cited by 58
Prenatal Hypoxia and Placental Oxidative Stress: Insights from Animal Models to Clinical Evidences
Silvestro, S., Calcaterra, V., Pelizzo, G., Bramanti, P., & Mazzon, E. (2020) · Antioxidants · doi:10.3390/antiox9050414 · Cited by 67
Endothelial cell function in patients with Down's syndrome
Cappelli-Bigazzi, M., Santoro, G., Battaglia, C., Palladino, M. T., Carrozza, M., Russo, M. G., Pacileo, G., & Calabrò, R. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.04.047 · Cited by 58
Apoptosis, Neurotrophic Factors and Neurodegeneration
Dragunow, M., MacGibbon, G. A., Lawlor, P. A., Butterworth, N. J., Connor, B. J., Henderson, C. E., Walton, M. R., Woodgate, A.-M., Hughes, P. E., & Faull, R. L. M. (1997) · Reviews in the Neurosciences · doi:10.1515/revneuro.1997.8.3-4.223 · Cited by 64
Chen, H., Xu, X., & Zhu, Y. (2010) · PubMed · Cited by 57
Flentjar, N. J., Crack, P. J., Boyd, R. L., Malin, M., de Haan, J. B., Hertzog, P. J., Kola, I., & Iannello, R. C. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7927 · Cited by 58
Haney, M. J., Suresh, P., Zhao, Y., Kanmogne, G. D., Kadiu, I., Sokolsky-Papkov, M., Klyachko, N. L., Mosley, R. L., Kabanov, A. V., Gendelman, H. E., et al. (2012) · Nanomedicine · doi:10.2217/nnm.11.156 · Cited by 57
Rimbau, V., Camins, A., Pubill, D., Sureda, F. X., Romay, C., González, R., Jiménez, A., Escubedo, E., Camarasa, J., & Pallàs, M. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100100437 · Cited by 65
“Therefore, agents that prevent ROS formation are expected to exert protective actions in neurons subjected to oxidative stress ( Busciglio and Yankner 1995; Sun and Chen 1998; Sastry and Rao 2000).”
BackgroundProtection against MPP+ neurotoxicity in cerebellar granule cells by antioxidants
González‐Polo, R. A., Soler, G., Rodrıguezmartın, A., Morán, J. M., & Fuentes, J. M. (2004) · Cell Biology International · doi:10.1016/j.cellbi.2004.03.005 · Cited by 57
“The generation of free radicals such as RNS and ROS is thought to play an important role in neuronal loss in many neurodegenerative disorders, including Parkinson’s disease (Busciglio and Yankner, 1995; Deng et al., 1993; Robberecht et al., 1994).”
BackgroundAberrant expression of bcl-2 gene family in Down's syndrome brains
Sawa, A., Oyama, F., Cairns, N. J., Amano, N., & Matsushita, M. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00078-8 · Cited by 57
Metabolomic analysis for first-trimester Down syndrome prediction
Bahado-Singh, R. O., Akolekar, R., Mandal, R., Dong, E., Xia, J., Kruger, M. L., Wishart, D. S., & Nicolaides, K. H. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.12.035 · Cited by 61
Lin, T., Zhou, D., Dong, J. W., Jiang, F., & Chen, W. (2016) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2016.06.047 · Cited by 56
Heat-shock protein 70 levels in brain of patients with Down Syndrome and Alzheimer’s disease
Yoo, B. C., Seidl, R., Cairns, N. J., & Lübec, G. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_22 · Cited by 64
Peroxiredoxin 2 ( PRDX2 ), an antioxidant enzyme, is underexpressed in Down syndrome fetal brains
Sánchez-Font, M. F., Sebasti�, J., Sanfeliu, C., Crist�fol, R., Marfany, G., & Gonz�les-Duarte, R. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3048-1 · Cited by 57
Suzuki, H., Kumagai, T., Goto, A., & Sugiura, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9181 · Cited by 56
Rodríguez-Sureda, V., Vilches, Á., Sánchez, O., Audí, L., & Domínguez, C. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/509241 · Cited by 54
Morphological characteristics of apoptosis and its significance in neurogenesis
Kalinichenko, S. G., & Matveeva, N. Y. (2008) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-008-0046-7 · Cited by 59
“Anomalously high rates of apoptosis are a cause of neuronal depletion in Down’s syndrome, Alzheimer’s disease, Huntingdon’s chorea, and AIDS dementia [24, 31].”
Background
Metadata
- Authors
- Busciglio, J., & Yankner, B. A.
- Affiliations
- Boston Children's Hospital (US)
- Venue
- Nature
- Published
- 1995-12
- Volume
- 378
- Issue
- 6559
- Pages
- 776-779
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1992689843
- Cited by
- 741
- References
- 26
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 6 · 2023: 16 · 2022: 13 · 2021: 13 · 2020: 16 · 2019: 19 · 2018: 16 · 2017: 15 · 2016: 21 · 2015: 21 · 2014: 25 · 2013: 30 · 2012: 32
- FWCI
- 57.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- Down syndrome, neuronal apoptosis, reactive oxygen species, lipid peroxidation, cortical neurons, neurodegeneration, radical scavengers, catalase, Alzheimer's disease, intellectual disability, oxidative stress
- MeSH terms
- Alzheimer Disease, Antioxidants, Cell Differentiation, Cells, Cultured, Cerebral Cortex, Cycloheximide, Dactinomycin, Down Syndrome, Fluoresceins, Humans, Nerve Degeneration, Neurons, Lipid Peroxidation, Free Radical Scavengers, Apoptosis, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.